Minimal Risk Levels (MRLs) List
MRL List – June 2017 (PDF) [55 KB]
|
ATSDR Minimal Risk Levels (MRLs) - June 2017 |
|||||||||
| Route | Duration | MRL | Factors | Endpoint | Draft/ Final | Cover Date | CAS Number | ||
| ACENAPHTHENE | |||||||||
| Oral | Int. | 0.6 mg/kg/day | 300 | Hepatic | Final | 08/1995 | 83-32-9 | ||
| ACETONE | |||||||||
| Inh. | Acute | 26 ppm | 9 | Neurol. | Final | 05/1994 | 67-64-1 | ||
| Inh. | Int. | 13 ppm | 100 | Neurol. | Final | 05/1994 | 67-64-1 | ||
| Inh. | Chr. | 13 ppm | 100 | Neurol. | Final | 05/1994 | 67-64-1 | ||
| Oral | Int. | 2 mg/kg/day | 100 | Hemato. | Final | 05/1994 | 67-64-1 | ||
| ACROLEIN | |||||||||
| Inh. | Acute | 0.003 ppm | 100 | Resp. | Final | 08/2007 | 107-02-8 | ||
| Inh. | Int. | 0.00004 ppm | 300 | Resp. | Final | 08/2007 | 107-02-8 | ||
| Oral | Int. | 0.004 mg/kg/day | 100 | Gastro. | Final | 08/2007 | 107-02-8 | ||
| ACRYLAMIDE | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 30 | Repro. | Final | 12/2012 | 79-06-1 | ||
| Oral | Int. | 0.001 mg/kg/day | 30 | Neurol. | Final | 12/2012 | 79-06-1 | ||
| Oral | Chr. | 0.001 mg/kg/day | 30 | Neurol. | Final | 12/2012 | 79-06-1 | ||
| ACRYLONITRILE | |||||||||
| Inh. | Acute | 0.1 ppm | 10 | Neurol. | Final | 12/1990 | 107-13-1 | ||
| Oral | Acute | 0.1 mg/kg/day | 100 | Develop. | Final | 12/1990 | 107-13-1 | ||
| Oral | Int. | 0.01 mg/kg/day | 1000 | Repro. | Final | 12/1990 | 107-13-1 | ||
| Oral | Chr. | 0.04 mg/kg/day | 100 | Hemato. | Final | 12/1990 | 107-13-1 | ||
| ALDRIN | |||||||||
| Oral | Acute | 0.002 mg/kg/day | 1000 | Develop. | Final | 09/2002 | 309-00-2 | ||
| Oral | Chr. | 0.00003 mg/kg/day | 1000 | Hepatic | Final | 09/2002 | 309-00-2 | ||
| ALUMINUM | |||||||||
| Oral | Int. | 1.0 mg/kg/day | 30 | Neurol. | Final | 09/2008 | 7429-90-5 | ||
| Oral | Chr. | 1.0 mg/kg/day | 90 | Neurol. | Final | 09/2008 | 7429-90-5 | ||
| AMERICIUM | |||||||||
| Rad. | Acute | 4 mSv | 3 | Develop. | Final | 04/2004 | 7440-35-9 | ||
| Rad. | Chr. | 1 mSv/yr | 3 | Other | Final | 04/2004 | 7440-35-9 | ||
| AMMONIA | |||||||||
| Inh. | Acute | 1.7 ppm | 30 | Resp. | Final | 09/2004 | 7664-41-7 | ||
| Inh. | Chr. | 0.1 ppm | 30 | Resp. | Final | 09/2004 | 7664-41-7 | ||
| ANTHRACENE | |||||||||
| Oral | Int. | 10 mg/kg/day | 100 | Hepatic | Final | 08/1995 | 120-12-7 | ||
| ANTIMONY | |||||||||
| Inh | Acute | 0.001 mg/m3 | 30 | Resp. | Draft | 04/2017 | 7440-36-0 | ||
| Inh. | Int. | 0.001 mg/m3 | 30 | Resp. | Draft | 04/2017 | 7440-36-0 | ||
| Inh. | Chr. | 0.0003 mg/m3 | 30 | Resp. | Draft | 04/2017 | 7440-36-0 | ||
| Oral | Acute | 1 mg/kg/day | 100 | Hepatic | Draft | 04/2017 | 7440-36-0 | ||
| Oral | Int. | 0.0006 mg/kg/day | 100 | Metab. | Draft | 04/2017 | 7440-36-0 | ||
| ARSENIC | |||||||||
| Oral | Acute | 0.005 mg/kg/day | 10 | Gastro. | Final | 08/2007 | 7440-38-2 | ||
| Oral | Chr. | 0.0003 mg/kg/day | 3 | Dermal | Final | 08/2007 | 7440-38-2 | ||
| ATRAZINE | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Body Wt. | Final | 09/2003 | 1912-24-9 | ||
| Oral | Int. | 0.003 mg/kg/day | 300 | Repro. | Final | 09/2003 | 1912-24-9 | ||
| 1-BROMOPROPANE | |||||||||
| Inh. | Acute | 1 ppm | 30 | Neurol. | Draft | 01/2016 | 106-94-5 | ||
| Inh. | Int. | 0.1 ppm | 30 | Neurol. | Draft | 01/2016 | 106-94-5 | ||
| Inh. | Chr. | 0.02 ppm | 30 | Neurol. | Draft | 01/2016 | 106-94-5 | ||
| Oral | Acute | 0.2 mg/kg/day | 100 | Neurol. | Draft | 01/2016 | 106-94-5 | ||
| 2-BUTOXYETHANOL | |||||||||
| Inh. | Acute | 6 ppm | 9 | Hemato. | Final | 08/1998 | 111-76-2 | ||
| Inh. | Int. | 3 ppm | 9 | Hemato. | Final | 08/1998 | 111-76-2 | ||
| Inh. | Chr. | 0.2 ppm | 3 | Hemato. | Final | 08/1998 | 111-76-2 | ||
| Oral | Acute | 0.4 mg/kg/day | 90 | Hemato. | Final | 08/1998 | 111-76-2 | ||
| Oral | Int. | 0.07 mg/kg/day | 1000 | Hepatic | Final | 08/1998 | 111-76-2 | ||
| BARIUM, SOLUBLE SALTS | |||||||||
| Oral | Int. | 0.2 mg/kg/day | 300 | Renal | Final | 08/2007 | 7440-39-3 | ||
| Oral | Chr. | 0.2 mg/kg/day | 300 | Renal | Final | 08/2007 | 7440-39-3 | ||
| BENZENE | |||||||||
| Inh. | Acute | 0.009 ppm | 300 | Immuno. | Final | 08/2007 | 71-43-2 | ||
| Inh. | Int. | 0.006 ppm | 300 | Immuno. | Final | 08/2007 | 71-43-2 | ||
| Inh. | Chr. | 0.003 ppm | 10 | Immuno. | Final | 08/2007 | 71-43-2 | ||
| Oral | Chr. | 0.0005 mg/kg/day | 30 | Immuno. | Final | 08/2007 | 71-43-2 | ||
| BERYLLIUM | |||||||||
| Oral | Chr. | 0.002 mg/kg/day | 300 | Gastro. | Final | 09/2002 | 7440-41-7 | ||
| BIS(2 CHLOROETHYL) ETHER | |||||||||
| Inh. | Int. | 0.02 ppm | 1000 | Body Wt. | Final | 12/1989 | 111-44-4 | ||
| BIS(CHLOROMETHYL) ETHER | |||||||||
| Inh. | Int. | 0.0003 ppm | 100 | Resp. | Final | 12/1989 | 542-88-1 | ||
| BORON AND COMPOUNDS | |||||||||
| Inh. | Acute | 0.3 mg/m3 | 3 | Resp. | Final | 11/2010 | 7440-42-8 | ||
| Oral | Acute | 0.2 mg/kg/day | 100 | Develop. | Final | 11/2010 | 7440-42-8 | ||
| Oral | Int. | 0.2 mg/kg/day | 66 | Develop. | Final | 11/2010 | 7440-42-8 | ||
| BROMODICHLOROMETHANE | |||||||||
| Oral | Acute | 0.04 mg/kg/day | 1000 | Hepatic | Final | 12/1989 | 75-27-4 | ||
| Oral | Chr. | 0.02 mg/kg/day | 1000 | Renal | Final | 12/1989 | 75-27-4 | ||
| BROMOFORM | |||||||||
| Oral | Acute | 0.7 mg/kg/day | 100 | Hepatic | Final | 08/2005 | 75-25-2 | ||
| Oral | Int. | 0.2 mg/kg/day | 100 | Hepatic | Final | 08/2005 | 75-25-2 | ||
| Oral | Chr. | 0.02 mg/kg/day | 3000 | Hepatic | Final | 08/2005 | 75-25-2 | ||
| BROMOMETHANE | |||||||||
| Inh. | Acute | 0.05 ppm | 100 | Neurol. | Final | 09/1992 | 74-83-9 | ||
| Inh. | Int. | 0.05 ppm | 100 | Neurol. | Final | 09/1992 | 74-83-9 | ||
| Inh. | Chr. | 0.005 ppm | 100 | Neurol. | Final | 09/1992 | 74-83-9 | ||
| Oral | Int. | 0.003 mg/kg/day | 100 | Gastro. | Final | 09/1992 | 74-83-9 | ||
| 4-CHLOROPHENOL | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Hepatic | Final | 07/1999 | 106-48-9 | ||
| CADMIUM | |||||||||
| Inh. | Acute | 0.00003 mg/m3 | 300 | Resp. | Final | 09/2012 | 7440-43-9 | ||
| Inh. | Chr. | 0.00001 mg/m3 | 9 | Renal | Final | 09/2012 | 7440-43-9 | ||
| Oral | Int. | 0.0005 mg/kg/day | 100 | Musculo. | Final | 09/2012 | 7440-43-9 | ||
| Oral | Chr. | 0.0001 mg/kg/day | 3 | Renal | Final | 09/2012 | 7440-43-9 | ||
| CARBON DISULFIDE | |||||||||
| Inh. | Chr. | 0.3 ppm | 30 | Neurol. | Final | 08/1996 | 75-15-0 | ||
| Oral | Acute | 0.01 mg/kg/day | 300 | Hepatic | Final | 08/1996 | 75-15-0 | ||
| CARBON TETRACHLORIDE | |||||||||
| Inh. | Int. | 0.03 ppm | 30 | Hepatic | Final | 08/2005 | 56-23-5 | ||
| Inh. | Chr. | 0.03 ppm | 30 | Hepatic | Final | 08/2005 | 56-23-5 | ||
| Oral | Acute | 0.02 mg/kg/day | 300 | Hepatic | Final | 08/2005 | 56-23-5 | ||
| Oral | Int. | 0.007 mg/kg/day | 100 | Hepatic | Final | 08/2005 | 56-23-5 | ||
| CESIUM | |||||||||
| Rad. | Acute | 4 mSv | 3 | Develop. | Final | 04/2004 | 7440-46-2 | ||
| Rad. | Chr. | 1 mSv/yr | 3 | Other | Final | 04/2004 | 7440-46-2 | ||
| CHLORDANE | |||||||||
| Inh. | Int. | 0.0002 mg/m3 | 100 | Hepatic | Final | 05/1994 | 57-74-9 | ||
| Inh. | Chr. | 0.00002 mg/m3 | 1000 | Hepatic | Final | 05/1994 | 57-74-9 | ||
| Oral | Acute | 0.001 mg/kg/day | 1000 | Develop. | Final | 05/1994 | 57-74-9 | ||
| Oral | Int. | 0.0006 mg/kg/day | 100 | Hepatic | Final | 05/1994 | 57-74-9 | ||
| Oral | Chr. | 0.0006 mg/kg/day | 100 | Hepatic | Final | 05/1994 | 57-74-9 | ||
| CHLORDECONE | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Neurol. | Final | 08/1995 | 143-50-0 | ||
| Oral | Int. | 0.0005 mg/kg/day | 100 | Renal | Final | 08/1995 | 143-50-0 | ||
| Oral | Chr. | 0.0005 mg/kg/day | 100 | Renal | Final | 08/1995 | 143-50-0 | ||
| CHLORFENVINPHOS | |||||||||
| Oral | Acute | 0.002 mg/kg/day | 1000 | Neurol. | Final | 09/1997 | 470-90-6 | ||
| Oral | Int. | 0.002 mg/kg/day | 1000 | Immuno. | Final | 09/1997 | 470-90-6 | ||
| Oral | Chr. | 0.0007 mg/kg/day | 1000 | Neurol. | Final | 09/1997 | 470-90-6 | ||
| CHLORINE | |||||||||
| Inh. | Acute | 0.06 ppm | 3 | Resp. | Final | 11/2010 | 7782-50-5 | ||
| Inh. | Int. | 0.002 ppm | 90 | Resp. | Final | 11/2010 | 7782-50-5 | ||
| Inh. | Chr. | 0.00005 ppm | 30 | Resp. | Final | 11/2010 | 7782-50-5 | ||
| CHLORINE DIOXIDE | |||||||||
| Inh. | Int. | 0.001 ppm | 300 | Resp. | Final | 09/2004 | 10049-04-4 | ||
| CHLORITE | |||||||||
| Oral | Int. | 0.1 mg/kg/day | 30 | Develop. | Final | 09/2004 | 7758-19-2 | ||
| CHLOROBENZENE | |||||||||
| Oral | Int. | 0.4 mg/kg/day | 100 | Hepatic | Final | 12/1990 | 108-90-7 | ||
| CHLOROETHANE | |||||||||
| Inh. | Acute | 15 ppm | 100 | Develop. | Final | 12/1998 | 75-00-3 | ||
| CHLOROFORM | |||||||||
| Inh. | Acute | 0.1 ppm | 30 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| Inh. | Int. | 0.05 ppm | 300 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| Inh. | Chr. | 0.02 ppm | 100 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| Oral | Acute | 0.3 mg/kg/day | 100 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| Oral | Int. | 0.1 mg/kg/day | 100 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| Oral | Chr. | 0.01 mg/kg/day | 1000 | Hepatic | Final | 09/1997 | 67-66-3 | ||
| CHLOROMETHANE | |||||||||
| Inh. | Acute | 0.5 ppm | 100 | Neurol. | Final | 12/1998 | 74-87-3 | ||
| Inh. | Int. | 0.2 ppm | 300 | Hepatic | Final | 12/1998 | 74-87-3 | ||
| Inh. | Chr. | 0.05 ppm | 1000 | Neurol. | Final | 12/1998 | 74-87-3 | ||
| CHLORPYRIFOS | |||||||||
| Oral | Acute | 0.003 mg/kg/day | 10 | Neurol. | Final | 09/1997 | 2921-88-2 | ||
| Oral | Int. | 0.003 mg/kg/day | 10 | Neurol. | Final | 09/1997 | 2921-88-2 | ||
| Oral | Chr. | 0.001 mg/kg/day | 100 | Neurol. | Final | 09/1997 | 2921-88-2 | ||
| CHROMIUM(III) INSOL. PARTICULATES | |||||||||
| Inh. | Int. | 0.005 mg/m3 | 90 | Resp. | Final | 09/2012 | 16065-83-1 | ||
| CHROMIUM(III) SOLUBLE PARTICULATES | |||||||||
| Inh. | Int. | 0.0001 mg/m3 | 300 | Resp. | Final | 09/2012 | 16065-83-1 | ||
| CHROMIUM(VI) | |||||||||
| Oral | Int. | 0.005 mg/kg/day | 100 | Hemato. | Final | 09/2012 | 18540-29-9 | ||
| Oral | Chr | 0.0009 mg/kg/day | 100 | Gastro. | Final | 09/2012 | 18540-29-9 | ||
| CHROMIUM(VI), AEROSOL MISTS | |||||||||
| Inh. | Int. | 0.000005 mg/m3 | 100 | Resp. | Final | 09/2012 | 18540-29-9 | ||
| Inh. | Chr. | 0.000005 mg/m3 | 100 | Resp. | Final | 09/2012 | 18540-29-9 | ||
| CHROMIUM(VI), PARTICULATES | |||||||||
| Inh. | Int. | 0.0003 mg/m3 | 30 | Resp. | Final | 09/2012 | 18540-29-9 | ||
| COBALT | |||||||||
| Inh. | Chr. | 0.0001 mg/m3 | 10 | Resp. | Final | 04/2004 | 7440-48-4 | ||
| Oral | Int. | 0.01 mg/kg/day | 100 | Hemato. | Final | 04/2004 | 7440-48-4 | ||
| Rad. | Acute | 4 mSv | 3 | Develop. | Final | 04/2004 | 7440-48-4 | ||
| Rad. | Chr. | 1 mSv/yr | 3 | Other | Final | 04/2004 | 7440-48-4 | ||
| COPPER | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 3 | Gastro. | Final | 09/2004 | 7440-50-8 | ||
| Oral | Int. | 0.01 mg/kg/day | 3 | Gastro. | Final | 09/2004 | 7440-50-8 | ||
| CRESOLS | |||||||||
| Oral | Int. | 0.1 mg/kg/day | 100 | Resp. | Final | 09/2008 | 1319-77-3 | ||
| Oral | Chr. | 0.1 mg/kg/day | 1000 | Resp. | Final | 09/2008 | 1319-77-3 | ||
| CYANIDE, SODIUM | |||||||||
| Oral | Int. | 0.05 mg/kg/day | 100 | Repro. | Final | 07/2006 | 143-33-9 | ||
| CYHALOTHRIN | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Gastro. | Final | 09/2003 | 68085-85-8 | ||
| Oral | Int. | 0.01 mg/kg/day | 100 | Gastro. | Final | 09/2003 | 68085-85-8 | ||
| CYPERMETHRIN | |||||||||
| Oral | Acute | 0.02 mg/kg/day | 1000 | Neurol. | Final | 09/2003 | 52315-07-8 | ||
| DIBROMOCHLOROMETHANE | |||||||||
| Oral | Acute | 0.1 mg/kg/day | 300 | Hepatic | Final | 08/2005 | 124-48-1 | ||
| Oral | Chr. | 0.09 mg/kg/day | 300 | Hepatic | Final | 08/2005 | 124-48-1 | ||
| 1,1-DICHLOROETHENE | |||||||||
| Inh. | Int. | 0.02 ppm | 100 | Hepatic | Final | 05/1994 | 75-35-4 | ||
| Oral | Chr. | 0.009 mg/kg/day | 1000 | Hepatic | Final | 05/1994 | 75-35-4 | ||
| 1,1-DIMETHYLHYDRAZINE | |||||||||
| Inh. | Int. | 0.0002 ppm | 300 | Hepatic | Final | 09/1997 | 57-14-7 | ||
| 1,2-DIBROMO-3-CHLOROPROPANE | |||||||||
| Inh. | Int. | 0.0002 ppm | 100 | Repro. | Final | 09/1992 | 96-12-8 | ||
| Oral | Int. | 0.002 mg/kg/day | 1000 | Repro. | Final | 09/1992 | 96-12-8 | ||
| 1,2-DICHLOROBENZENE | |||||||||
| Oral | Acute | 0.7 mg/kg/day | 100 | Hepatic | Final | 08/2006 | 95-50-1 | ||
| Oral | Int. | 0.6 mg/kg/day | 100 | Hepatic | Final | 08/2006 | 95-50-1 | ||
| Oral | Chr. | 0.3 mg/kg/day | 100 | Renal | Final | 08/2006 | 95-50-1 | ||
| 1,2-DICHLOROETHANE | |||||||||
| Inh. | Chr. | 0.6 ppm | 90 | Hepatic | Final | 09/2001 | 107-06-2 | ||
| Oral | Int. | 0.2 mg/kg/day | 300 | Renal | Final | 09/2001 | 107-06-2 | ||
| 1,2-DICHLOROETHENE, CIS- | |||||||||
| Oral | Acute | 1 mg/kg/day | 100 | Hemato. | Final | 08/1996 | 156-59-2 | ||
| Oral | Int. | 0.3 mg/kg/day | 100 | Hemato. | Final | 08/1996 | 156-59-2 | ||
| 1,2-DICHLOROETHENE, TRANS- | |||||||||
| Inh. | Acute | 0.2 ppm | 1000 | Hepatic | Final | 08/1996 | 156-60-5 | ||
| Inh. | Int. | 0.2 ppm | 1000 | Hepatic | Final | 08/1996 | 156-60-5 | ||
| Oral | Int. | 0.2 mg/kg/day | 100 | Hepatic | Final | 08/1996 | 156-60-5 | ||
| 1,2-DICHLOROPROPANE | |||||||||
| Inh. | Acute | 0.05 ppm | 1000 | Resp. | Final | 12/1989 | 78-87-5 | ||
| Inh. | Int. | 0.007 ppm | 1000 | Resp. | Final | 12/1989 | 78-87-5 | ||
| Oral | Acute | 0.1 mg/kg/day | 1000 | Neurol. | Final | 12/1989 | 78-87-5 | ||
| Oral | Int. | 0.07 mg/kg/day | 1000 | Hemato. | Final | 12/1989 | 78-87-5 | ||
| Oral | Chr. | 0.09 mg/kg/day | 1000 | Hepatic | Final | 12/1989 | 78-87-5 | ||
| 1,2-DIMETHYLHYDRAZINE | |||||||||
| Oral | Int. | 0.0008 mg/kg/day | 1000 | Hepatic | Final | 09/1997 | 540-73-8 | ||
| 1,3-DICHLOROBENZENE | |||||||||
| Oral | Acute | 0.4 mg/kg/day | 100 | Hepatic | Final | 08/2006 | 541-73-1 | ||
| Oral | Int. | 0.02 mg/kg/day | 100 | Endocr. | Final | 08/2006 | 541-73-1 | ||
| 1,3-DICHLOROPROPENE | |||||||||
| Inh. | Int. | 0.008 ppm | 30 | Resp. | Final | 09/2008 | 542-75-6 | ||
| Inh. | Chr. | 0.007 ppm | 30 | Resp. | Final | 09/2008 | 542-75-6 | ||
| Oral | Int. | 0.04 mg/kg/day | 100 | Gastro. | Final | 09/2008 | 542-75-6 | ||
| Oral | Chr. | 0.03 mg/kg/day | 100 | Gastro. | Final | 09/2008 | 542-75-6 | ||
| 1,3-DINITROBENZENE | |||||||||
| Oral | Acute | 0.08 mg/kg/day | 100 | Repro. | Final | 06/1995 | 99-65-0 | ||
| Oral | Int. | 0.0005 mg/kg/day | 1000 | Hemato. | Final | 06/1995 | 99-65-0 | ||
| 1,4-DICHLOROBENZENE | |||||||||
| Inh. | Acute | 2 ppm | 10 | Resp. | Final | 08/2006 | 106-46-7 | ||
| Inh. | Int. | 0.2 ppm | 100 | Hepatic | Final | 08/2006 | 106-46-7 | ||
| Inh. | Chr. | 0.01 ppm | 30 | Resp. | Final | 08/2006 | 106-46-7 | ||
| Oral | Int. | 0.07 mg/kg/day | 100 | Hepatic | Final | 08/2006 | 106-46-7 | ||
| Oral | Chr. | 0.07 mg/kg/day | 100 | Hepatic | Final | 08/2006 | 106-46-7 | ||
| 1,4-DIOXANE | |||||||||
| Inh. | Acute | 2 ppm | 10 | Ocular | Final | 04/2012 | 123-91-1 | ||
| Inh. | Int. | 0.2 ppm | 30 | Resp. | Final | 04/2012 | 123-91-1 | ||
| Inh. | Chr. | 0.03 ppm | 300 | Resp. | Final | 04/2012 | 123-91-1 | ||
| Oral | Acute | 5 mg/kg/day | 100 | Develop. | Final | 04/2012 | 123-91-1 | ||
| Oral | Int. | 0.5 mg/kg/day | 100 | Hepatic | Final | 04/2012 | 123-91-1 | ||
| Oral | Chr. | 0.1 mg/kg/day | 100 | Hepatic | Final | 04/2012 | 123-91-1 | ||
| 2,3-DICHLOROPROPENE | |||||||||
| Inh. | Acute | 0.002 ppm | 90 | Resp. | Final | 09/2008 | 78-88-6 | ||
| 2,3-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.09 mg/kg/day | 3000 | Renal | Final | 02/2016 | 602-01-7 | ||
| 2,4-DICHLOROPHENOL | |||||||||
| Oral | Int. | 0.003 mg/kg/day | 100 | Immuno. | Final | 07/1999 | 120-83-2 | ||
| 2,4-DICHLOROPHENOXYACETIC ACID (2,4-D) | |||||||||
| Oral | Acute | 0.009 mg/kg/day | 100 | Develop. | Draft | 04/2017 | 94-75-7 | ||
| Oral | Int. | 0.009 mg/kg/day | 100 | Develop. | Draft | 04/2017 | 94-75-7 | ||
| 2,4-DINITROPHENOL | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Body Wt. | Final | 08/1995 | 51-28-5 | ||
| 2,4-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.05 mg/kg/day | 100 | Neurol. | Final | 02/2016 | 121-14-2 | ||
| Oral | Int. | 0.007 mg/kg/day | 100 | Hemato. | Final | 02/2016 | 121-14-2 | ||
| Oral | Chr. | 0.001 mg/kg/day | 100 | Hemato. | Final | 02/2016 | 121-14-2 | ||
| 2,5-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.007 mg/kg/day | 300 | Hemato. | Final | 02/2016 | 619-15-8 | ||
| 2,6-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.09 mg/kg/day | 100 | Hemato. | Final | 02/2016 | 606-20-2 | ||
| Oral | Int. | 0.004 mg/kg/day | 1000 | Hemato. | Final | 02/2016 | 606-20-2 | ||
| 3,4-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.03 mg/kg/day | 300 | Hemato. | Final | 02/2016 | 610-39-9 | ||
| 3,5-DINITROTOLUENE | |||||||||
| Oral | Acute | 0.03 mg/kg/day | 300 | Repro. | Final | 02/2016 | 618-85-9 | ||
| 4,6-DINITRO-O-CRESOL | |||||||||
| Oral | Acute | 0.004 mg/kg/day | 100 | Neurol. | Final | 08/1995 | 534-52-1 | ||
| Oral | Int. | 0.004 mg/kg/day | 100 | Neurol. | Final | 08/1995 | 534-52-1 | ||
| DDT, P,P'- | |||||||||
| Oral | Acute | 0.0005 mg/kg/day | 1000 | Develop. | Final | 09/2002 | 50-29-3 | ||
| Oral | Int. | 0.0005 mg/kg/day | 100 | Hepatic | Final | 09/2002 | 50-29-3 | ||
| DEET (N,N-DIETHYL-META-TOLUAMIDE) | |||||||||
| Oral | Int. | 1 mg/kg/day | 100 | Develop. | Draft | 09/2015 | 134-62-3 | ||
| DI(2-ETHYLHEXYL)PHTHALATE | |||||||||
| Oral | Int. | 0.1 mg/kg/day | 100 | Repro. | Final | 09/2002 | 117-81-7 | ||
| Oral | Chr. | 0.06 mg/kg/day | 100 | Repro. | Final | 09/2002 | 117-81-7 | ||
| DIAZINON | |||||||||
| Inh. | Int. | 0.01 mg/m3 | 30 | Neurol. | Final | 09/2008 | 333-41-5 | ||
| Oral | Acute | 0.006 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 333-41-5 | ||
| Oral | Int. | 0.002 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 333-41-5 | ||
| Oral | Chr. | 0.0007 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 333-41-5 | ||
| DICHLORVOS | |||||||||
| Inh. | Acute | 0.002 ppm | 100 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| Inh. | Int. | 0.0003 ppm | 100 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| Inh. | Chr. | 0.00006 ppm | 100 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| Oral | Acute | 0.004 mg/kg/day | 1000 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| Oral | Int. | 0.003 mg/kg/day | 10 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| Oral | Chr. | 0.0005 mg/kg/day | 100 | Neurol. | Final | 09/1997 | 62-73-7 | ||
| DIELDRIN | |||||||||
| Oral | Int. | 0.0001 mg/kg/day | 100 | Neurol. | Final | 09/2002 | 60-57-1 | ||
| Oral | Chr. | 0.00005 mg/kg/day | 100 | Hepatic | Final | 09/2002 | 60-57-1 | ||
| DIETHYL PHTHALATE | |||||||||
| Oral | Acute | 7 mg/kg/day | 300 | Repro. | Final | 06/1995 | 84-66-2 | ||
| Oral | Int. | 6 mg/kg/day | 300 | Hepatic | Final | 06/1995 | 84-66-2 | ||
| DIISOPROPYL METHYLPHOSPHONATE (DIMP) | |||||||||
| Oral | Int. | 0.8 mg/kg/day | 100 | Hemato. | Final | 08/1998 | 1445-75-6 | ||
| Oral | Chr. | 0.6 mg/kg/day | 100 | Hemato. | Final | 08/1998 | 1445-75-6 | ||
| DIMETHYLARSINIC ACID (DMA) | |||||||||
| Oral | Chr. | 0.02 mg/kg/day | 100 | Renal | Final | 08/2007 | 75-60-5 | ||
| DI-N-BUTYL PHTHALATE | |||||||||
| Oral | Acute | 0.5 mg/kg/day | 100 | Develop. | Final | 09/2001 | 84-74-2 | ||
| DI-N-OCTYL PHTHALATE | |||||||||
| Oral | Acute | 3 mg/kg/day | 300 | Hepatic | Final | 09/1997 | 117-84-0 | ||
| Oral | Int. | 0.4 mg/kg/day | 100 | Hepatic | Final | 09/1997 | 117-84-0 | ||
| DISULFOTON | |||||||||
| Inh. | Acute | 0.006 mg/m3 | 30 | Neurol. | Final | 08/1995 | 298-04-4 | ||
| Inh. | Int. | 0.0002 mg/m3 | 30 | Neurol. | Final | 08/1995 | 298-04-4 | ||
| Oral | Acute | 0.001 mg/kg/day | 100 | Neurol. | Final | 08/1995 | 298-04-4 | ||
| Oral | Int. | 0.00009 mg/kg/day | 100 | Develop. | Final | 08/1995 | 298-04-4 | ||
| Oral | Chr. | 0.00006 mg/kg/day | 1000 | Neurol. | Final | 08/1995 | 298-04-4 | ||
| ENDOSULFAN | |||||||||
| Oral | Acute | 0.007 mg/kg/day | 100 | Neurol. | Final | 08/2015 | 115-29-7 | ||
| Oral | Int. | 0.005 mg/kg/day | 100 | Immuno. | Final | 08/2015 | 115-29-7 | ||
| Oral | Chr. | 0.005 mg/kg/day | 100 | Immuno. | Final | 08/2015 | 115-29-7 | ||
| ENDRIN | |||||||||
| Oral | Int. | 0.002 mg/kg/day | 100 | Neurol. | Final | 08/1996 | 72-20-8 | ||
| Oral | Chr. | 0.0003 mg/kg/day | 100 | Neurol. | Final | 08/1996 | 72-20-8 | ||
| ETHION | |||||||||
| Oral | Acute | 0.002 mg/kg/day | 30 | Neurol. | Final | 09/2000 | 563-12-2 | ||
| Oral | Int. | 0.002 mg/kg/day | 30 | Neurol. | Final | 09/2000 | 563-12-2 | ||
| Oral | Chr. | 0.0004 mg/kg/day | 150 | Neurol. | Final | 09/2000 | 563-12-2 | ||
| ETHYLBENZENE | |||||||||
| Inh. | Acute | 5 ppm | 30 | Neurol. | Final | 11/2010 | 100-41-4 | ||
| Inh. | Int. | 2 ppm | 30 | Neurol. | Final | 11/2010 | 100-41-4 | ||
| Inh. | Chr. | 0.06 ppm | 300 | Renal | Final | 11/2010 | 100-41-4 | ||
| Oral | Int. | 0.4 mg/kg/day | 30 | Hepatic | Final | 11/2010 | 100-41-4 | ||
| ETHYLENE GLYCOL | |||||||||
| Inh. | Acute | 2 mg/m3 | 10 | Renal | Final | 11/2010 | 107-21-1 | ||
| Oral | Acute | 0.8 mg/kg/day | 100 | Develop. | Final | 11/2010 | 107-21-1 | ||
| Oral | Int. | 0.8 mg/kg/day | 100 | Develop. | Final | 11/2010 | 107-21-1 | ||
| ETHYLENE OXIDE | |||||||||
| Inh. | Int. | 0.09 ppm | 100 | Renal | Final | 12/1990 | 75-21-8 | ||
| FLUORANTHENE | |||||||||
| Oral | Int. | 0.4 mg/kg/day | 300 | Hepatic | Final | 08/1995 | 206-44-0 | ||
| FLUORENE | |||||||||
| Oral | Int. | 0.4 mg/kg/day | 300 | Hepatic | Final | 08/1995 | 86-73-7 | ||
| FLUORIDE, SODIUM | |||||||||
| Oral | Chr. | 0.05 mg/kg/day | 3 | Musculo. | Final | 09/2003 | 7681-49-4 | ||
| FLUORINE | |||||||||
| Inh. | Acute | 0.01 ppm | 10 | Resp. | Final | 09/2003 | 7782-41-4 | ||
| FORMALDEHYDE | |||||||||
| Inh. | Acute | 0.04 ppm | 9 | Resp. | Final | 07/1999 | 50-00-0 | ||
| Inh. | Int. | 0.03 ppm | 30 | Resp. | Final | 07/1999 | 50-00-0 | ||
| Inh. | Chr. | 0.008 ppm | 30 | Resp. | Final | 07/1999 | 50-00-0 | ||
| Oral | Int. | 0.3 mg/kg/day | 100 | Gastro. | Final | 07/1999 | 50-00-0 | ||
| Oral | Chr. | 0.2 mg/kg/day | 100 | Gastro. | Final | 07/1999 | 50-00-0 | ||
| FUEL OIL NO.2 | |||||||||
| Inh. | Acute | 0.02 mg/m3 | 1000 | Neurol. | Final | 06/1995 | 68476-30-2 | ||
| GLUTARALDEHYDE | |||||||||
| Inh. | Acute | 0.001 ppm | 3 | Resp. | Draft | 12/2015 | 111-30-8 | ||
| Inh. | Int. | 0.00003 ppm | 3 | Resp. | Draft | 12/2015 | 111-30-8 | ||
| Oral | Chr. | 0.1 mg/kg/day | 30 | Gastro. | Draft | 12/2015 | 111-30-8 | ||
| GUTHION (AZINPHOS-METHYL) | |||||||||
| Inh. | Acute | 0.02 mg/m3 | 30 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| Inh. | Int. | 0.01 mg/m3 | 30 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| Inh. | Chr. | 0.01 mg/m3 | 30 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| Oral | Acute | 0.01 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| Oral | Int. | 0.003 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| Oral | Chr. | 0.003 mg/kg/day | 100 | Neurol. | Final | 09/2008 | 86-50-0 | ||
| HEPTACHLOR | |||||||||
| Oral | Acute | 0.0006 mg/kg/day | 3000 | Repro. | Final | 08/2007 | 76-44-8 | ||
| Oral | Int. | 0.0001 mg/kg/day | 300 | Immuno. | Final | 08/2007 | 76-44-8 | ||
| HEXACHLOROBENZENE | |||||||||
| Oral | Acute | 0.008 mg/kg/day | 300 | Develop. | Final | 08/2015 | 118-74-1 | ||
| Oral | Int. | 0.0001 mg/kg/day | 90 | Repro. | Final | 08/2015 | 118-74-1 | ||
| Oral | Chr. | 0.00007 mg/kg/day | 300 | Hepatic | Final | 08/2015 | 118-74-1 | ||
| HEXACHLOROBUTADIENE | |||||||||
| Oral | Int. | 0.0002 mg/kg/day | 1000 | Renal | Final | 05/1994 | 87-68-3 | ||
| HEXACHLOROCYCLOHEXANE, ALPHA- | |||||||||
| Oral | Chr. | 0.008 mg/kg/day | 100 | Hepatic | Final | 08/2005 | 319-84-6 | ||
| HEXACHLOROCYCLOHEXANE, BETA- | |||||||||
| Oral | Acute | 0.05 mg/kg/day | 100 | Neurol. | Final | 08/2005 | 319-85-7 | ||
| Oral | Int. | 0.0006 mg/kg/day | 300 | Hepatic | Final | 08/2005 | 319-85-7 | ||
| HEXACHLOROCYCLOHEXANE, GAMMA- | |||||||||
| Oral | Acute | 0.003 mg/kg/day | 300 | Reprod. | Final | 08/2005 | 58-89-9 | ||
| Oral | Int. | 0.00001 mg/kg/day | 1000 | Immuno. | Final | 08/2005 | 58-89-9 | ||
| HEXACHLOROCYCLOPENTADIENE | |||||||||
| Inh. | Int. | 0.01 ppm | 30 | Resp. | Final | 07/1999 | 77-47-4 | ||
| Inh. | Chr. | 0.0002 ppm | 90 | Resp. | Final | 07/1999 | 77-47-4 | ||
| Oral | Int. | 0.1 mg/kg/day | 100 | Renal | Final | 07/1999 | 77-47-4 | ||
| HEXACHLOROETHANE | |||||||||
| Inh. | Acute | 6 ppm | 30 | Neurol. | Final | 09/1997 | 67-72-1 | ||
| Inh. | Int. | 6 ppm | 30 | Neurol. | Final | 09/1997 | 67-72-1 | ||
| Oral | Acute | 1 mg/kg/day | 100 | Hepatic | Final | 09/1997 | 67-72-1 | ||
| Oral | Int. | 0.01 mg/kg/day | 100 | Hepatic | Final | 09/1997 | 67-72-1 | ||
| HEXAMETHYLENE DIISOCYANATE | |||||||||
| Inh. | Int. | 0.00003 ppm | 30 | Resp. | Final | 08/1998 | 822-06-0 | ||
| Inh. | Chr. | 0.00001 ppm | 90 | Resp. | Final | 08/1998 | 822-06-0 | ||
| HEXANE, N- | |||||||||
| Inh. | Chr. | 0.6 ppm | 100 | Neurol. | Final | 07/1999 | 110-54-3 | ||
| HMX (CYCLOTETRAMETHYLENE TETRANITRAMINE) | |||||||||
| Oral | Acute | 0.1 mg/kg/day | 1000 | Neurol. | Final | 09/1997 | 2691-41-0 | ||
| Oral | Int. | 0.05 mg/kg/day | 1000 | Hepatic | Final | 09/1997 | 2691-41-0 | ||
| HYDRAZINE | |||||||||
| Inh. | Int. | 0.004 ppm | 300 | Hepatic | Final | 09/1997 | 302-01-2 | ||
| HYDROGEN FLUORIDE | |||||||||
| Inh. | Acute | 0.02 ppm | 30 | Resp. | Final | 09/2003 | 7664-39-3 | ||
| HYDROGEN SULFIDE | |||||||||
| Inh. | Acute | 0.07 ppm | 27 | Resp. | Final | 11/2016 | 7783-06-4 | ||
| Inh. | Int. | 0.02 ppm | 30 | Resp. | Final | 11/2016 | 7783-06-4 | ||
| IODIDE | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 1 | Endocr. | Final | 04/2004 | 7553-56-2 | ||
| Oral | Chr. | 0.01 mg/kg/day | 1 | Endocr. | Final | 04/2004 | 7553-56-2 | ||
| IONIZING RADIATION, N.O.S. | |||||||||
| Rad. | Acute | 4 mSv | 3 | Neurol. | Final | 09/1999 | HZ1800-45-T | ||
| Rad. | Chr. | 1 mSv/yr | 3 | Other | Final | 09/1999 | HZ1800-45-T | ||
| ISOPHORONE | |||||||||
| Oral | Int. | 3 mg/kg/day | 100 | Other | Final | 12/1989 | 78-59-1 | ||
| Oral | Chr. | 0.2 mg/kg/day | 1000 | Hepatic | Final | 12/1989 | 78-59-1 | ||
| JP-4 | |||||||||
| Inh. | Int. | 9 mg/m3 | 300 | Hepatic | Final | 06/1995 | 50815-00-4 | ||
| JP-5 | |||||||||
| Inh. | Int. | 2 mg/m3 | 90 | Hepatic | Final | 03/2017 | 8008-20-6 | ||
| JP-7 | |||||||||
| Inh. | Chr. | 0.3 mg/m3 | 300 | Hepatic | Final | 06/1995 | HZ0600-22-T | ||
| JP-8 | |||||||||
| Inh. | Int. | 3 mg/m3 | 30 | Neurol. | Final | 03/2017 | 8008-20-6 | ||
| Oral | Acute | 3 mg/kg/day | 100 | Immuno. | Final | 03/2017 | 8008-20-6 | ||
| Oral | Int. | 0.3 mg/kg/day | 1000 | Develop. | Final | 03/2017 | 8008-20-6 | ||
| KEROSENE | |||||||||
| Inh. | Int. | 0.01 mg/m3 | 1000 | Hepatic | Final | 06/1995 | 8008-20-6 | ||
| 1-METHYLNAPHTHALENE | |||||||||
| Oral | Chr. | 0.07 mg/kg/day | 1000 | Resp. | Final | 08/2005 | 90-12-0 | ||
| 2-METHYLNAPHTHALENE | |||||||||
| Oral | Chr. | 0.04 mg/kg/day | 100 | Resp. | Final | 08/2005 | 91-57-6 | ||
| 4,4'-METHYLENEBIS(2-CHLOROANILINE) | |||||||||
| Oral | Chr. | 0.003 mg/kg/day | 3000 | Hepatic | Final | 05/1994 | 101-14-4 | ||
| 4,4'-METHYLENEDIANILINE | |||||||||
| Oral | Acute | 0.2 mg/kg/day | 300 | Hepatic | Final | 08/1998 | 101-77-9 | ||
| Oral | Int. | 0.08 mg/kg/day | 100 | Hepatic | Final | 08/1998 | 101-77-9 | ||
| MALATHION | |||||||||
| Inh. | Acute | 0.2 mg/m3 | 100 | Neurol. | Final | 09/2003 | 121-75-5 | ||
| Inh. | Int. | 0.02 mg/m3 | 1000 | Resp. | Final | 09/2003 | 121-75-5 | ||
| Oral | Int. | 0.02 mg/kg/day | 10 | Neurol. | Final | 09/2003 | 121-75-5 | ||
| Oral | Chr. | 0.02 mg/kg/day | 100 | Neurol. | Final | 09/2003 | 121-75-5 | ||
| MANGANESE, RESPIRABLE | |||||||||
| Inh. | Chr. | 0.3 ug/m3 | 100 | Neurol. | Final | 09/2012 | 7439-96-5 | ||
| MERCURIC CHLORIDE | |||||||||
| Oral | Acute | 0.007 mg/kg/day | 100 | Renal | Final | 03/1999 | 7487-94-7 | ||
| Oral | Int. | 0.002 mg/kg/day | 100 | Renal | Final | 03/1999 | 7487-94-7 | ||
| MERCURY | |||||||||
| Inh. | Chr. | 0.0002 mg/m3 | 30 | Neurol. | Final | 03/1999 | 7439-97-6 | ||
| METHOXYCHLOR | |||||||||
| Oral | Int. | 0.005 mg/kg/day | 1000 | Repro. | Final | 09/2002 | 72-43-5 | ||
| METHYL PARATHION | |||||||||
| Oral | Int. | 0.0007 mg/kg/day | 300 | Neurol. | Final | 09/2001 | 298-00-0 | ||
| Oral | Chr. | 0.0003 mg/kg/day | 100 | Hemato. | Final | 09/2001 | 298-00-0 | ||
| METHYLENE CHLORIDE | |||||||||
| Inh. | Acute | 0.6 ppm | 100 | Neurol. | Final | 09/2000 | 75-09-2 | ||
| Inh. | Int. | 0.3 ppm | 90 | Hepatic | Final | 09/2000 | 75-09-2 | ||
| Inh. | Chr. | 0.3 ppm | 30 | Hepatic | Final | 09/2000 | 75-09-2 | ||
| Oral | Acute | 0.2 mg/kg/day | 100 | Neurol. | Final | 09/2000 | 75-09-2 | ||
| Oral | Chr. | 0.06 mg/kg/day | 100 | Hepatic | Final | 09/2000 | 75-09-2 | ||
| METHYLENEDIPHENYL DIISOCYANATE (MDI) | |||||||||
| Inh. | Chr. | 0.001 mg/m3 | 30 | Resp. | Draft | 09/2015 | 101-68-8 | ||
| METHYLMERCURY | |||||||||
| Oral | Chr. | 0.0003 mg/kg/day | 4.5 | Develop. | Final | 03/1999 | 22967-92-6 | ||
| METHYL-T-BUTYL ETHER | |||||||||
| Inh. | Acute | 2 ppm | 100 | Neurol. | Final | 08/1996 | 1634-04-4 | ||
| Inh. | Int. | 0.7 ppm | 100 | Neurol. | Final | 08/1996 | 1634-04-4 | ||
| Inh. | Chr. | 0.7 ppm | 100 | Renal | Final | 08/1996 | 1634-04-4 | ||
| Oral | Acute | 0.4 mg/kg/day | 100 | Neurol. | Final | 08/1996 | 1634-04-4 | ||
| Oral | Int. | 0.3 mg/kg/day | 300 | Hepatic | Final | 08/1996 | 1634-04-4 | ||
| MIREX | |||||||||
| Oral | Chr. | 0.0008 mg/kg/day | 100 | Hepatic | Final | 08/1995 | 2385-85-5 | ||
| MOLYBDENUM | |||||||||
| Inh. | Chr. | 0.0004 mg/m3 | 30 | Resp. | Draft | 04/2017 | 7439-98-7 | ||
| Oral | Acute. | 0.05 mg/kg/day | 100 | Repro. | Draft | 04/2017 | 7439-98-7 | ||
| Oral | Int. | 0.008 mg/kg/day | 100 | Repro. | Draft | 04/2017 | 7439-98-7 | ||
| MONOMETHYLARSONIC ACID (MMA) | |||||||||
| Oral | Int. | 0.1 mg/kg/day | 100 | Gastro. | Final | 08/2007 | 124-58-3 | ||
| Oral | Chr. | 0.01 mg/kg/day | 100 | Renal | Final | 08/2007 | 124-58-3 | ||
| NAPHTHALENE | |||||||||
| Inh. | Chr. | 0.0007 ppm | 300 | Resp. | Final | 08/2005 | 91-20-3 | ||
| Oral | Acute | 0.6 mg/kg/day | 90 | Neurol. | Final | 08/2005 | 91-20-3 | ||
| Oral | Int. | 0.6 mg/kg/day | 90 | Neurol. | Final | 08/2005 | 91-20-3 | ||
| NICKEL | |||||||||
| Inh. | Int. | 0.0002 mg/m3 | 30 | Resp. | Final | 08/2005 | 7440-02-0 | ||
| Inh. | Chr. | 0.00009 mg/m3 | 30 | Resp. | Final | 08/2005 | 7440-02-0 | ||
| NITRATE | |||||||||
| Oral | Acute | 4 mg/kg/day | 1 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| Oral | Int. | 4 mg/kg/day | 1 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| Oral | Chr. | 4 mg/kg/day | 1 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| NITRITE | |||||||||
| Oral | Acute | 0.1 mg/kg/day | 2 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| Oral | Int. | 0.1 mg/kg/day | 2 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| Oral | Chr. | 0.1 mg/kg/day | 2 | Hemato. | Draft | 09/2015 | 84145-82-4 | ||
| N-NITROSODI-N-PROPYLAMINE | |||||||||
| Oral | Acute | 0.095 mg/kg/day | 100 | Hepatic | Final | 12/1989 | 621-64-7 | ||
| 2,3,4,7,8-PENTACHLORODIBENZOFURAN | |||||||||
| Oral | Acute | 0.001 ug/kg/day | 3000 | Immuno. | Final | 05/1994 | 57117-31-4 | ||
| Oral | Int. | 0.00003 ug/kg/day | 3000 | Hepatic | Final | 05/1994 | 57117-31-4 | ||
| PARATHION | |||||||||
| Inh. | Int. | 20 ng/m3 | 100 | Neurol. | Final | 01/2017 | 56-38-2 | ||
| Oral | Int. | 0.009 mg/kg/day | 10 | Neurol. | Final | 01/2017 | 56-38-2 | ||
| PBDE, DECABROMINATED | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Develop. | Final | 03/2017 | 67774-32-7 | ||
| Oral | Int. | 0.0002 mg/kg/day | 300 | Endocr. | Final | 03/2017 | 67774-32-7 | ||
| PENTACHLOROPHENOL | |||||||||
| Oral | Acute | 0.005 mg/kg/day | 1000 | Develop. | Final | 09/2001 | 87-86-5 | ||
| Oral | Int. | 0.001 mg/kg/day | 1000 | Repro. | Final | 09/2001 | 87-86-5 | ||
| Oral | Chr. | 0.001 mg/kg/day | 1000 | Endocr. | Final | 09/2001 | 87-86-5 | ||
| PERCHLORATES | |||||||||
| Oral | Chr. | 0.0007 mg/kg/day | 10 | Endocr. | Final | 09/2008 | 7778-74-7 | ||
| PERFLUOROOCTANE SULFONIC ACID (PFOS) | |||||||||
| Oral | Int. | 0.00003 mg/kg/day | 90 | Hepatic | Draft | 08/2015 | 1763-23-1 | ||
| PERFLUOROOCTANOIC ACID (PFOA) | |||||||||
| Oral | Int. | 0.00002 mg/kg/day | 90 | Hepatic | Draft | 08/2015 | 355-67-1 | ||
| PERMETHRIN | |||||||||
| Oral | Acute | 0.3 mg/kg/day | 100 | Neurol. | Final | 09/2003 | 52645-53-1 | ||
| Oral | Int. | 0.2 mg/kg/day | 100 | Neurol. | Final | 09/2003 | 52645-53-1 | ||
| PHENOL | |||||||||
| Oral | Acute | 1 mg/kg/day | 100 | Body Wt. | Final | 09/2008 | 108-95-2 | ||
| PHOSPHORUS, WHITE | |||||||||
| Inh. | Acute | 0.02 mg/m3 | 30 | Resp. | Final | 09/1997 | 7723-14-0 | ||
| Oral | Int. | 0.0002 mg/kg/day | 100 | Repro. | Final | 09/1997 | 7723-14-0 | ||
| POLYBROMINATED BIPHENYLS (PBBS) | |||||||||
| Oral | Acute | 0.01 mg/kg/day | 100 | Endocr. | Final | 09/2004 | 36355-01-8 | ||
| POLYBROMINATED DIPHENYL ETHERS (PBDES), LOWER BROMINATED | |||||||||
| Inh. | Int. | 0.006 mg/m3 | 90 | Endocr. | Final | 03/2017 | 32536-52-0 | ||
| Oral | Acute | 0.00006 mg/kg/day | 1000 | Develop. | Final | 03/2017 | 60348-60-9 | ||
| Oral | Int. | 0.000003 mg/kg/day | 300 | Reprod. | Final | 03/2017 | 5436-43-1 | ||
| POLYCHLORINATED BIPHENYLS (PCBs) (Aroclor 1254) | |||||||||
| Oral | Int. | 0.03 ug/kg/day | 300 | Neurol. | Final | 11/2000 | 11097-69-1 | ||
| Oral | Chr. | 0.02 ug/kg/day | 300 | Immuno. | Final | 11/2000 | 11097-69-1 | ||
| PROPYLENE GLYCOL | |||||||||
| Inh. | Int. | 0.009 ppm | 1000 | Resp. | Final | 09/1997 | 57-55-6 | ||
| PROPYLENE GLYCOL DINITRATE | |||||||||
| Inh. | Acute | 0.003 ppm | 10 | Neurol. | Final | 06/1995 | 6423-43-4 | ||
| Inh. | Int. | 0.00004 ppm | 1000 | Hemato. | Final | 06/1995 | 6423-43-4 | ||
| Inh. | Chr. | 0.00004 ppm | 1000 | Hemato. | Final | 06/1995 | 6423-43-4 | ||
| RDX (CYCLONITE) | |||||||||
| Oral | Acute | 0.2 mg/kg/day | 30 | Neurol. | Final | 01/2012 | 121-82-4 | ||
| Oral | Int. | 0.1 mg/kg/day | 30 | Neurol. | Final | 01/2012 | 121-82-4 | ||
| Oral | Chr. | 0.1 mg/kg/day | 30 | Neurol. | Final | 01/2012 | 121-82-4 | ||
| REFRACTORY CERAMIC FIBERS | |||||||||
| Inh. | Chr. | 0.03 fibers/cc | 30 | Resp. | Final | 09/2004 | HZ0900-26-T | ||
| SELENIUM | |||||||||
| Oral | Chr. | 0.005 mg/kg/day | 3 | Dermal | Final | 09/2003 | 7782-49-2 | ||
| STRONTIUM | |||||||||
| Oral | Int. | 2 mg/kg/day | 90 | Musculo. | Final | 04/2004 | 7440-24-6 | ||
| STYRENE | |||||||||
| Inh. | Acute | 5 ppm | 10 | Neurol. | Final | 11/2010 | 100-42-5 | ||
| Inh. | Chr. | 0.2 ppm | 30 | Neurol. | Final | 11/2010 | 100-42-5 | ||
| Oral | Acute | 0.1 mg/kg/day | 1000 | Neurol. | Final | 11/2010 | 100-42-5 | ||
| SULFUR DIOXIDE | |||||||||
| Inh. | Acute | 0.01 ppm | 9 | Resp. | Final | 12/1998 | 7446-09-5 | ||
| SULFUR MUSTARD | |||||||||
| Inh. | Acute | 0.0007 mg/m3 | 30 | Ocular | Final | 09/2003 | 505-60-2 | ||
| Inh. | Int. | 0.00002 mg/m3 | 30 | Ocular | Final | 09/2003 | 505-60-2 | ||
| Oral | Acute | 0.5 µg/kg/day | 1000 | Develop. | Final | 09/2003 | 505-60-2 | ||
| Oral | Int. | 0.07 µg/kg/day | 300 | Gastro. | Final | 09/2003 | 505-60-2 | ||
| 1,1,1-TRICHLOROETHANE | |||||||||
| Inh. | Acute | 2 ppm | 100 | Neurol. | Final | 07/2006 | 71-55-6 | ||
| Inh. | Int. | 0.7 ppm | 100 | Neurol. | Final | 07/2006 | 71-55-6 | ||
| Oral | Int. | 20 mg/kg/day | 100 | Body Wt. | Final | 07/2006 | 71-55-6 | ||
| 1,1,2,2-TETRACHLOROETHANE | |||||||||
| Oral | Int. | 0.5 mg/kg/day | 100 | Hepatic | Final | 09/2008 | 79-34-5 | ||
| 1,1,2-TRICHLOROETHANE | |||||||||
| Oral | Acute | 0.3 mg/kg/day | 100 | Neurol. | Final | 12/1989 | 79-00-5 | ||
| Oral | Int. | 0.04 mg/kg/day | 100 | Hepatic | Final | 12/1989 | 79-00-5 | ||
| 1,2,3-TRICHLOROPROPANE | |||||||||
| Inh. | Acute | 0.0003 ppm | 100 | Resp. | Final | 09/1992 | 96-18-4 | ||
| Oral | Int. | 0.06 mg/kg/day | 100 | Hepatic | Final | 09/1992 | 96-18-4 | ||
| 1,2,4 - TRICHLOROBENZENE | |||||||||
| Oral | Int. | 0.1 mg/kg/day | 100 | Hepatic | Final | 10/2014 | 120-82-1 | ||
| Oral | Chr. | 0.1 mg/kg/day | 100 | Hepatic | Final | 10/2014 | 120-82-1 | ||
| 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN | |||||||||
| Oral | Acute | 0.0002 ug/kg/day | 21 | Immuno. | Final | 12/1998 | 1746-01-6 | ||
| Oral | Int. | 0.00002 ug/kg/day | 30 | Lymphor. | Final | 12/1998 | 1746-01-6 | ||
| Oral | Chr. | 0.000001 ug/kg/day | 90 | Develop. | Final | 12/1998 | 1746-01-6 | ||
| 2,4,6-TRINITROTOLUENE | |||||||||
| Oral | Int. | 0.0005 mg/kg/day | 1000 | Hepatic | Final | 06/1995 | 118-96-7 | ||
| TETRACHLOROETHYLENE | |||||||||
| Inh. | Acute | 0.006 ppm | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| Inh. | Int. | 0.006 ppm | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| Inh. | Chr. | 0.006 ppm | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| Oral | Acute | 0.008 mg/kg/day | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| Oral | Int. | 0.008 mg/kg/day | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| Oral | Chr. | 0.008 mg/kg/day | 300 | Neurol. | Draft | 10/2014 | 127-18-4 | ||
| TIN, DIBUTYL-, DICHLORIDE | |||||||||
| Oral | Int. | 0.005 mg/kg/day | 1000 | Immuno. | Final | 08/2005 | 683-18-1 | ||
| TIN, INORGANIC | |||||||||
| Oral | Int. | 0.3 mg/kg/day | 100 | Hemato. | Final | 08/2005 | 7440-31-5 | ||
| TIN, TRIBUTYL-, OXIDE | |||||||||
| Oral | Int. | 0.0003 mg/kg/day | 100 | Immuno. | Final | 08/2005 | 56-35-9 | ||
| Oral | Chr. | 0.0003 mg/kg/day | 100 | Immuno. | Final | 08/2005 | 56-36-9 | ||
| TITANIUM TETRACHLORIDE | |||||||||
| Inh. | Int. | 0.01 mg/m3 | 90 | Resp. | Final | 09/1997 | 7550-45-0 | ||
| Inh. | Chr. | 0.0001 mg/m3 | 90 | Resp. | Final | 09/1997 | 7550-45-0 | ||
| TOLUENE | |||||||||
| Inh. | Acute | 2 ppm | 9 | Neurol. | Draft | 09/2015 | 108-88-3 | ||
| Inh. | Chr. | 1 ppm | 10 | Neurol. | Draft | 09/2015 | 108-88-3 | ||
| Oral | Acute | 0.8 mg/kg/day | 300 | Neurol. | Draft | 09/2015 | 108-88-3 | ||
| Oral | Int. | 0.2 mg/kg/day | 100 | Immuno. | Draft | 09/2015 | 108-88-3 | ||
| TOLUENE DIISOCYANATE | |||||||||
| Inh. | Acute | 0.00001 ppm | 100 | Resp. | Draft | 09/2015 | 26471-62-5 | ||
| Inh. | Chr. | 0.000003 ppm | 100 | Resp. | Draft | 09/2015 | 26471-62-5 | ||
| TOXAPHENE | |||||||||
| Oral | Acute | 0.05 mg/kg/day | 100 | Neurol. | Final | 10/2014 | 8001-35-2 | ||
| Oral | Int. | 0.002 mg/kg/day | 100 | Immuno. | Final | 10/2014 | 8001-35-2 | ||
| TRIBUTYL PHOSPHATE (TNBP) | |||||||||
| Oral | Acute | 1.1 mg/kg/day | 100 | Body Wt. | Final | 09/2012 | 126-73-8 | ||
| Oral | Int. | 0.08 mg/kg/day | 100 | Renal | Final | 09/2012 | 126-73-8 | ||
| Oral | Chr. | 0.08 mg/kg/day | 100 | Renal | Final | 09/2012 | 126-73-8 | ||
| TRICHLOROETHYLENE | |||||||||
| Inh. | Int. | 0.0004 ppm | 10 | Develop. | Draft | 10/2014 | 79-01-6 | ||
| 100 | Immuno. | ||||||||
| Inh. | Chr. | 0.0004 ppm | 10 | Develop. | Draft | 10/2014 | 79-01-6 | ||
| 100 | Immuno. | ||||||||
| Oral | Int. | 0.0005 mg/kg/day | 10 | Develop. | Draft | 10/2014 | 79-01-6 | ||
| 100 | Immuno. | ||||||||
| 1000 | Immuno. | ||||||||
| Oral | Chr. | 0.0005 mg/kg/day | 10 | Develop. | Draft | 10/2014 | 79-01-6 | ||
| 100 | Immuno. | ||||||||
| 1000 | Immuno. | ||||||||
| TRICRESYL PHOSPHATE (TCP) | |||||||||
| Oral | Int. | 0.04 mg/kg/day | 100 | Reprod. | Final | 09/2012 | 1330-78-5 | ||
| Oral | Chr. | 0.02 mg/kg/day | 100 | Reprod. | Final | 09/2012 | 1330-78-5 | ||
| TRIS(1,3-DICHLORO-2-PROPYL) PHOSPHATE (TDCP) | |||||||||
| Oral | Int. | 0.05 mg/kg/day | 100 | Renal | Final | 09/2012 | 13674-87-8 | ||
| Oral | Chr. | 0.02 mg/kg/day | 100 | Renal | Final | 09/2012 | 13674-87-8 | ||
| TRIS(2-BUTOXYETHYL) PHOSPHATE (TBEP) | |||||||||
| Oral | Acute | 4.8 mg/kg/day | 100 | Body Wt. | Final | 09/2012 | 78-51-3 | ||
| Oral | Int. | 0.09 mg/kg/day | 100 | Hepatic | Final | 09/2012 | 78-51-3 | ||
| TRIS(2-CHLOROETHYL) PHOSPHATE (TCEP) | |||||||||
| Oral | Int. | 0.6 mg/kg/day | 100 | Neurol. | Final | 09/2012 | 115-96-8 | ||
| Oral | Chr. | 0.2 mg/kg/day | 100 | Renal | Final | 09/2012 | 115-96-8 | ||
| URANIUM, INSOLUBLE COMPOUNDS | |||||||||
| Inh. | Int. | 0.002 mg/m3 | 100 | Renal | Final | 02/2013 | 7440-61-1 | ||
| Inh. | Chr. | 0.0008 mg/m3 | 1000 | Resp. | Final | 02/2013 | 7440-61-1 | ||
| URANIUM, SOLUBLE SALTS | |||||||||
| Inh. | Int. | 0.0001 mg/m3 | 300 | Renal | Final | 02/2013 | 7440-61-1 | ||
| Inh. | Chr. | 0.00004 mg/m3 | 100 | Renal | Final | 02/2013 | 7440-61-1 | ||
| Oral | Acute | 0.002 mg/kg/day | 100 | Develop. | Final | 02/2013 | 7440-61-1 | ||
| Oral | Int. | 0.0002 mg/kg/day | 300 | Renal | Final | 02/2013 | 7440-61-1 | ||
| VANADIUM | |||||||||
| Inh. | Acute | 0.0008 mg/m3 | 90 | Resp. | Final | 09/2012 | 7440-62-2 | ||
| Inh. | Chr. | 0.0001 mg/m3 | 30 | Resp. | Final | 09/2012 | 7440-62-2 | ||
| Oral | Int. | 0.01 mg/kg/day | 10 | Hemato. | Final | 09/2012 | 7440-62-2 | ||
| VINYL ACETATE | |||||||||
| Inh. | Int. | 0.01 ppm | 100 | Resp. | Final | 07/1992 | 108-05-4 | ||
| VINYL CHLORIDE | |||||||||
| Inh. | Acute | 0.5 ppm | 30 | Develop. | Final | 07/2006 | 75-01-4 | ||
| Inh. | Int. | 0.03 ppm | 30 | Hepatic | Final | 07/2006 | 75-01-4 | ||
| Oral | Chr. | 0.003 mg/kg/day | 30 | Hepatic | Final | 07/2006 | 75-01-4 | ||
| XYLENES, MIXED | |||||||||
| Inh. | Acute | 2 ppm | 30 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| Inh. | Int. | 0.6 ppm | 90 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| Inh. | Chr. | 0.05 ppm | 300 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| Oral | Acute | 1 mg/kg/day | 100 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| Oral | Int. | 0.4 mg/kg/day | 1000 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| Oral | Chr. | 0.2 mg/kg/day | 1000 | Neurol. | Final | 08/2007 | 1330-20-7 | ||
| ZINC | |||||||||
| Oral | Int. | 0.3 mg/kg/day | 3 | Hemato. | Final | 08/2005 | 7440-66-6 | ||
| Oral | Chr. | 0.3 mg/kg/day | 3 | Hemato. | Final | 08/2005 | 7440-66-6 | ||
Contact Us:
- Agency for Toxic Substances and Disease Registry
4770 Buford Hwy NE
Atlanta, GA 30341 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays
Contact CDC-INFO
